AlembicPharma gains 1% on USFDA nod for Teriflunomide tablets that treat sclerosis

Alembic Pharma now has a total of 91 ANDA approvals (79 final approvals and 12 tentative approvals) from USFDA.

Alembic Pharmaceuticals shares gained more than a percent intraday on April 22 after the #US health regulator approved Teriflunomide tablets, which are available in 7 mg and 14 mg strength.

For more information and best STOCK TIPS Call us ✆ – 0731-6642300 or Visit http://www.epicresearch.co

Connect with our social media sites

Facebook

Twitter

YouTube

Pinterest

Linkedin

Google+

Follow @Epic_Research